Screening for emotional distress is becoming increasingly common in cancer care. This
systematic review examines the psychometric properties of the existing tools used to screen …

Abstract Purpose The Hospital Anxiety and Depression Scale (HADS) is the most
extensively validated scale for screening emotional distress in cancer patients. However …

Background Substantial uncertainty exists about prevalence of mood disorders in patients
with cancer, including those in oncological, haematological, and palliative-care settings. We …

Background Major depression is an important complication of cancer. However, reliable
data are lacking for the prevalence of depression in patients with cancer in different primary …

OBJECTIVE: To examine the validity of the Hospital Anxiety and Depression Scale (HADS)
in the identification of psychiatric complications of cancer, as defined by a robust criterion …

The aim of this study was to determine optimal cutoff scores for the Hospital Anxiety and
Depression Scale (HADS) when used in evaluating cancer patients in acute care. A total of …

Purpose: The aim of this project was to identify the nature and range of needs, as well as
levels of quality of life (QOL), of both patients living with myeloma and their partners …

BACKGROUND Depression screening in patients with cancer is recommended by major
clinical guidelines, although the evidence on individual screening tools is limited for this …

Background Major depressive disorder severely impairs the quality of life of patients with
medical disorders such as cancer, but evidence to guide its management is scarce. We …

Abstract Background The Hospital Anxiety and Depression Scale (HADS) is a widely used
questionnaire in health research, but there is little guidance on how to handle missing items …